NLRC4 and cystic fibrosis: The molecular mechanism by which NLRC4 inhibits NLRP3 inflammasome activity remains unknown, but clinical evidence confirms that a certain NLRC4 polymorphism is associated with increased risk of fungal colonization in cystic fibrosis patients and infection (Iannitti et al, 2016; Zhong et al, 2022a).